Literature DB >> 6094435

Severe multiresistant Salmonella typhimurium systemic infections in Central Africa--clinical features and treatment in a paediatric department.

P Lepage, J Bogaerts, F Nsengumuremyi, D G Hitimana, C Van Goethem, J Vandepitte, J P Butzler.   

Abstract

During a 21-month period, we observed an outbreak of severe systemic infections due to multiresistant Salmonella typhimurium among 66 children in the in-patient Department of Paediatrics of Kigali, Rwanda. These infections were more likely to occur in subjects who had stayed for a long time in the hospital for severe illness and/or malnutrition. The children usually presented first with mild to moderate diarrhoea and fever. Later, sever pulmonary involvement was often noted (rales: 58%; respiratory distress: 42%). Moreover, there were four cases of abscess, three arthritis and one meningitis. Of the 66 children, 48 were treated with cefotaxime. The fatality-rate among this group was 10.4%. The fatality-rate among the 18 other untreated patients was 77.9%, suggesting a high efficiency of cefotaxime against these strains of multiresistant Salm. typhimurium.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094435     DOI: 10.1093/jac/14.suppl_b.153

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Oral ciprofloxacin treatment for Salmonella typhimurium infection of normal and immunocompromised mice.

Authors:  H Brunner; H J Zeiler
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

Review 2.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

3.  Metastatic focal infections due to multiresistant Salmonella typhimurium in children: a 34 month experience in Rwanda.

Authors:  P Lepage; J Bogaerts; F Nsengumuremyi; C Van Goethem; D G Hitimana; J Vandepitte; J P Butzler; J Levy
Journal:  Eur J Epidemiol       Date:  1986-06       Impact factor: 8.082

4.  Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.

Authors:  H Goossens; P De Mol; H Coignau; J Levy; O Grados; G Ghysels; H Innocent; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

5.  Typing of Salmonella enterica serotype paratyphi C isolates from various countries by plasmid profiles and pulsed-field gel electrophoresis.

Authors:  S Kariuki; J Cheesbrough; A K Mavridis; C A Hart
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

Review 6.  A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014).

Authors:  Ifeanyi Valentine Uche; Calman A MacLennan; Allan Saul
Journal:  PLoS Negl Trop Dis       Date:  2017-01-05

7.  Prevalence and characterization of Salmonella enterica from the feces of cattle, poultry, swine and hedgehogs in Burkina Faso and their comparison to human Salmonella isolates.

Authors:  Assèta Kagambèga; Taru Lienemann; Laura Aulu; Alfred S Traoré; Nicolas Barro; Anja Siitonen; Kaisa Haukka
Journal:  BMC Microbiol       Date:  2013-11-11       Impact factor: 3.605

8.  Invasive non-typhoidal Salmonella infections in sub-Saharan Africa: a systematic review on antimicrobial resistance and treatment.

Authors:  Bieke Tack; Jolien Vanaenrode; Jan Y Verbakel; Jaan Toelen; Jan Jacobs
Journal:  BMC Med       Date:  2020-07-17       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.